10-KT

SEC Filing Details

Document Details

Form
Filing Date
Mar 26, 2018
Document Date
Dec 31, 2017
Form Description
Annual transition reports filed rule 13a-10 or 15d-10 of the Securities Exchange Act
Filing Group
Annual Filings
Company
ContraVir Pharmaceuticals
Issuer
ContraVir Pharmaceuticals, Inc.